The intestinal microbiota and cardiovascular disease

被引:41
|
作者
Katsimichas, Themistoklis [1 ,2 ]
Antonopoulos, Alexios S. [1 ]
Katsimichas, Alexandros [1 ]
Ohtani, Tomohito [2 ]
Sakata, Yasushi [2 ]
Tousoulis, Dimitris [1 ]
机构
[1] Hippokrateion Hosp, Athens Med Sch, Cardiol Dept 1, Athens, Greece
[2] Osaka Univ, Grad Sch Med, Dept Cardiovasc Med, Suita, Osaka, Japan
关键词
Intestinal microbiota; Microbial analysis; Atherosclerosis; Heart failure; TMAO; CORONARY-ARTERY-DISEASE; TRIMETHYLAMINE-N-OXIDE; GUT MICROBIOTA; HEART-FAILURE; DIETARY FIBER; BLOOD-PRESSURE; SACCHAROMYCES-BOULARDII; CARDIAC INFLAMMATION; FISH CONSUMPTION; METAANALYSIS;
D O I
10.1093/cvr/cvz135
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
The intestinal microbiota of human hosts is the community of microorganisms living in the small and, mainly, the large intestine of humans. This microbial ecosystem has co-evolved with humans across the millennia, has come to play an important interactive role in human physiology and has been aptly called our forgotten organ. Significant properties of the microbiota benefiting its host include energy harvest from food sources indigestible by humans, protection from pathogen colonization, and vitamin synthesis. Mounting evidence has linked changes in the composition or metabolic profiles of the microbiota with human disease, including disorders of the cardiovascular spectrum. Although cause and effect mechanisms are as yet essentially unproven in the relevant literature, the established associations point to the importance of the microbiota in the pathophysiology of cardiovascular disease (CVD). In this review, we first summarize key information on the gut microbial communities and the elaborate tools developed to analyse their structure and metabolic functions. Ecological terms are explained and analytical techniques are simplified, to enhance the understanding of published studies. Statistical methods used in microbial analysis are also described in simple terms. We then present published literature on the association of the compositional and functional changes of the microbiota with CVD, including heart failure, hypertension, and atherosclerosis. Each section of the review deals with the underlying pathophysiology of the relevant associations, connecting the observational and mechanistic aspects. Finally, we discuss the challenges that remain to be met before this field of research can generate knowledge which can impact everyday clinical practice.
引用
收藏
页码:1471 / 1486
页数:16
相关论文
共 50 条
  • [1] The role of intestinal microbiota in cardiovascular disease
    Jin, Mengchao
    Qian, Zhiyuan
    Yin, Jiayu
    Xu, Weiting
    Zhou, Xiang
    [J]. JOURNAL OF CELLULAR AND MOLECULAR MEDICINE, 2019, 23 (04) : 2343 - 2350
  • [2] Intestinal Microbiota in Cardiovascular Health and Disease
    Tang, W. H. Wilson
    Backhed, Fredrik
    Landmesser, Ulf
    Hazen, Stanley L.
    [J]. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2019, 73 (16) : 2089 - 2105
  • [3] The Neuroimmune Role of Intestinal Microbiota in the Pathogenesis of Cardiovascular Disease
    Suslov, Andrey V.
    Chairkina, Elizaveta
    Shepetovskaya, Maria D.
    Suslova, Irina S.
    Khotina, Victoria A.
    Kirichenko, Tatiana V.
    Postnov, Anton Y.
    [J]. JOURNAL OF CLINICAL MEDICINE, 2021, 10 (09)
  • [4] The Intriguing Link between the Intestinal Microbiota and Cardiovascular Disease
    Lippi, Giuseppe
    Danese, Elisa
    Mattiuzzi, Camilla
    Favaloro, Emmanuel J.
    [J]. SEMINARS IN THROMBOSIS AND HEMOSTASIS, 2017, 43 (06): : 609 - 613
  • [5] The role of intestinal microbiota in the development of dyslipidemia and cardiovascular disease risk
    Bogoslav, T., V
    [J]. ZAPOROZHYE MEDICAL JOURNAL, 2024, 26 (02) : 149 - 153
  • [6] ROLE OF INTESTINAL MICROBIOTA IN CARDIOVASCULAR DISEASE RISK IN END STAGE RENAL DISEASE PATIENTS
    Okba, Ashraf
    Shahin, Rasha
    Attallah, Aber
    Sheha, Dina
    Mkawy, Mohamed
    Farag, Moataz
    [J]. NEPHROLOGY DIALYSIS TRANSPLANTATION, 2018, 33 : 573 - 574
  • [7] Role of altered intestinal microbiota in systemic inflammation and cardiovascular disease in chronic kidney disease
    Mafra, Denise
    Lobo, Julie C.
    Barros, Amanda F.
    Koppe, Laetitia
    Vaziri, Nosratola D.
    Fouque, Denis
    [J]. FUTURE MICROBIOLOGY, 2014, 9 (03) : 399 - 410
  • [8] The intestinal microbiota in health and disease
    Day, Andrew S.
    Keenan, Jacqueline I.
    Tannock, Gerald W.
    [J]. JOURNAL OF THE ROYAL SOCIETY OF NEW ZEALAND, 2020, 50 (03) : 367 - 370
  • [9] Intestinal Microbiota in Hirschsprung Disease
    Neuvonen, Malla I.
    Korpela, Katri
    Kyrklund, Kristiina
    Salonen, Anne
    de Vos, Willem
    Rintala, Risto J.
    Pakarinen, Mikko P.
    [J]. JOURNAL OF PEDIATRIC GASTROENTEROLOGY AND NUTRITION, 2018, 67 (05): : 594 - 600
  • [10] Intestinal microbiota and neurological disease
    Wekerle, H.
    [J]. JOURNAL OF THE NEUROLOGICAL SCIENCES, 2019, 405